M1RN34:BVMF
Moderna Inc Bdr
R$56.00
0.00%
(0.00) 1D
Okt 9, 5:06:00 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa M1RN34...
Buksan
R$49.70
Mataas
R$56.00
Mababa
R$49.30
Mkt. cap
89.83B
Avg. na dami
105.76K
Dami
237.49K
Mataas nang 52-wk
R$56.00
Mababa nang 52-wk
R$6.02
Mga natitirang share
399.24M
Bilang ng mga empleyado
5K
Buksan
R$49.70
Mataas
R$56.00
Mababa
R$49.30
Mkt. cap
89.83B
Avg. na dami
105.76K
Dami
237.49K
Mataas nang 52-wk
R$56.00
Mababa nang 52-wk
R$6.02
Mga natitirang share
399.24M
Bilang ng mga empleyado
5K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
JournalArta
·
9 oras ang nakalipas
Covid vaccine stock S&P leader surges: What to Know
Simply Wall Street
·
15 oras ang nakalipas
Moderna Stock Surge Puts These Oncology Biotechs On Retail Investors Radar
NAI500
·
1 araw ang nakalipas
Moderna Stock Soars as New Cancer Research Initiative Ignites Market Enthusiasm
StocksToTrade
·
2 araw ang nakalipas
MRNA Stock Jumps As Nasdaq-100 Inclusion Meets Oncology Push
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Tungkol sa Moderna Inc Bdr